Your Cart is Empty


“Vitamin B12 was administered intravenously and transdermally to eight surgical patients to determine the systemic bioavailability and rate of absorption of the transdermally administered drug. Serum vitamin B concentrations reached a plateau approximately 4-8 h after placement of the transdermal vitamin delivery system. This plateau was maintained until removal of the system at 6 h. The decline in serum vitamin B12 concentrations after removal of the transdermal system had a terminal half-life of 17.0 +/- 2.3 h (mean +/- SD), considerably longer than the terminal elimination half-life seen after intravenous administration of vitamin B12 in the same patients (6.1 +/- 2.0 h). The rate of Vitamin B12 absorption, predicted to be 100 micrograms/h from in vitro data, appeared to be relatively constant during a period starting 4-8 h after placement of the transdermal system until removal of the system at 8h. The rate of absorption during this period was 91.7 +/- 25.7 micrograms/h. After removal of the transdermal vitamin B12 delivery system, absorption continued at a declining rate. This indicates that the long terminal half-life of serum Vitamin B12 concentrations after transdermal system removal is due to continued slow absorption of B12, probably from a cutaneous depot of drug at the site of prior transdermal system placement. At the time of removal of the transdermal vitamin B12 system, 1.07 +/- 0.43 mg of drug remained in this depot. Systemic vitamin B12 bioavailability was found to be 0.92 +/- 0.33, with no evidence of significant cutaneous metabolism or degradation by the skin's bacterial flora. The transdermal administration of vitamin B12 produces relatively constant serum concentrations for significant periods of time.”